Oxysterols in cancer management: From therapy to biomarkers

Alzbeta Kloudova-Spalenkova1,2,3, Petr Holy1,2,3, Pavel Soucek1,3

  • 1Department of Toxicogenomics, National Institute of Public Health, Prague, Czech Republic.

Insights

Oxysterols, oxidized cholesterol, impact cancer development and therapy. Research shows their potential as cancer biomarkers and therapeutic agents, influencing treatment efficacy and patient stratification.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Oxysterols are oxidized cholesterol derivatives with roles in various pathologies, notably cancer.
  • They influence key cancer processes like carcinogenesis, proliferation, migration, and apoptosis.
  • Oxysterols modulate cancer therapy, affecting hormone-positive breast cancer and chemotherapy efficacy.

Purpose of the Study:

  • To review the multifaceted roles of oxysterols in cancer.
  • To explore their impact on cancer therapy, including chemotherapy and immunotherapy.
  • To highlight the potential of oxysterols as cancer biomarkers.

Main Methods:

  • Literature review of studies on oxysterols in cancer.
  • Analysis of oxysterol effects on cancer cell signaling pathways.
  • Examination of oxysterol interactions with cancer treatments.

Main Results:

  • Oxysterols influence cancer cell proliferation, migration, and apoptosis.
  • They modulate the efficacy of various chemotherapeutic agents (e.g., doxorubicin, cisplatin).
  • Oxysterols affect estrogen receptor activity in breast cancer therapy.
  • Their impact on the immune system is relevant for immunotherapy.
  • Differences in oxysterol levels serve as potential cancer biomarkers.

Conclusions:

  • Oxysterols play significant roles in cancer development and progression.
  • They represent promising candidates for novel anti-cancer therapeutics.
  • Oxysterols are valuable biomarkers for cancer management and personalized therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K